Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Paul Edison, Eleni Frangou et al.|Trials|2019Cited by 214
Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s DiseaseStewart F. Graham, Brian D. Green, Olivier Chevallier et al.|PLoS ONE|2015Cited by 192
Alzheimer's disease–like pathology has transient effects on the brain and blood metabolomeXiaobei Pan, Brian D. Green, Muhammad Luqman Nasaruddin et al.|Neurobiology of Aging|2015Cited by 129
Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-ReviewBenjamin Brian Alexander McNaull, Anthony Peter Passmore, Stephen Todd et al.|Gerontology|2009Cited by 121
CSF Beta-amyloid 1–42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort StudyEmma Cunningham, Anthony Peter Passmore, Bernadette McGuinness et al.|Annals of Surgery|2018Cited by 98